Terumo Corp. To Acquire OrganOx Limited In $1.5 Bln Deal

(RTTNews) - Terumo Corp. (TRUMF) has agreed to acquire all outstanding shares of OrganOx Limited, a company specializing in organ preservation devices. The total transaction value is approximately $1.5 billion.

Founded in 2008 by Professor Peter Friend and Professor Constantin Coussios as a spin-off from the University of Oxford, OrganOx is a pioneering medical technology company specializing in advanced organ preservation devices for Normothermic Machine Perfusion (NMP). NMP and other ex-vivo machine perfusion (EVMP) technologies can preserve organs longer by circulating oxygen and nutrient rich perfusate through the organ at near-body temperature. In addition, NMP devices enable real-time monitoring of organ condition during storage and transport.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.